NERVOUS SYSTEM DISEASES
Clinical trials for NERVOUS SYSTEM DISEASES explained in plain language.
Never miss a new study
Get alerted when new NERVOUS SYSTEM DISEASES trials appear
Sign up with your email to follow new studies for NERVOUS SYSTEM DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dosing strategy aims to make Alzheimer's drug safer
Disease control OngoingThis study tests whether changing the dose schedule of donanemab can lower the risk of a brain swelling side effect called ARIA-E while still clearing amyloid plaques. About 1,175 adults with early symptomatic Alzheimer's will receive different dosing regimens over 91 weeks. The …
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 07:57 UTC
-
Experimental cell therapy aims to slow muscle loss in duchenne MD
Disease control OngoingThis phase 3 trial tests whether a cell therapy called deramiocel (CAP-1002) can slow muscle decline in boys and young men with Duchenne muscular dystrophy (DMD). About 106 participants receive either the therapy or a placebo every 3 months for a year, then all can receive the th…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: PHASE3 • Sponsor: Capricor Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Tai chi offers Drug-Free sleep relief for breast cancer survivors
Symptom relief OngoingThis study looks at whether Tai Chi, a gentle moving meditation, can improve chronic insomnia in breast cancer survivors. About 90 women who have finished cancer treatment and have had trouble sleeping for at least 6 months will practice Tai Chi or receive another treatment. Rese…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New headset lets ALS patients type with their brain
Knowledge-focused OngoingThis study is testing a new, comfortable headset that reads brain signals to help people with ALS communicate by typing on a virtual keyboard. The headset uses dry electrodes and is designed for daily use. Five people with ALS will try the device, and researchers will measure how…
Matched conditions: NERVOUS SYSTEM DISEASES
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated May 17, 2026 08:03 UTC